Women's Health

Considerations for Smarter Evidence Generation in Women’s Health

Lindus Staff
Author

Introduction

Women’s health has long been overlooked in clinical research, leading to gaps in treatment options, limited safety data, and barriers to access. Optimizing the patient journey in women’s health research—both clinical trials and real-world evidence (RWE) studies—is critical to improving recruitment, retention, and overall study outcomes. By addressing the unique elements of women’s health and adopting patient-centric execution tactics, sponsors can enhance engagement and generate more meaningful data.

Enhancing Awareness and Access to Clinical Trials

Many women remain unaware of research opportunities, or they assume participation will be too burdensome. Effective awareness and access strategies include:

  • Community and Provider Partnerships: Engaging OB/GYNs, primary care providers, and women’s health organizations to inform potential participants about trial opportunities.
  • Culturally Tailored Outreach: Messaging should be inclusive and address the specific concerns of diverse populations, ensuring that underrepresented groups are reached.
  • Digital Recruitment Strategies: Leveraging social media, patient advocacy groups, and online health communities to increase trial visibility and provide accessible information.

Accounting for Physiological Factors

Women’s unique physiological factors such as menstrual cycle fluctuations, pregnancy, menopause, and hormonal therapies can impact trial design and data interpretation. To optimize outcomes in clinical trials and RWE studies, sponsors must:

  • Address Hormonal Considerations: Ensure study protocols account for hormonal variations that may affect drug metabolism and efficacy.
  • Understand Sex-Related Health Factors: Women have different risk factors for and presentation of certain medical conditions (i.e. cardiovascular events, osteoporosis).
  • Enroll Diverse Patient Populations: Recruit participants of various demographics to understand how factors like race, ethnicity, age, and socioeconomic status can affect health outcomes and the performance of an investigational product.
  • Include Pregnant and Lactating Patients: When safe, allow pregnant and breastfeeding participants or establish registries to collect real-world safety data.
  • Stratify Data Analysis: Ensure statistical analysis plans produce results accounting for different life stages, from reproductive years to postmenopause.

Designing Research That Fits into Women’s Lives

Caregiving responsibilities, work obligations, and disparities in healthcare access are all common logistical barriers in women’s health research. Leveraging patient-centric study designs can mitigate these challenges, improving recruitment, retention, and protocol adherence.

Virtual and Hybrid Research Models

Offering at-home data collection options, telemedicine visits, and mobile nursing services can reduce the burden of in-person visits. For studies that do require some on-site participation, it’s important to consolidate in-person study activities as much as possible to reduce the need for extraneous visits.

Flexible Scheduling

Researchers can improve accessibility and retention in their clinical trials and RWE studies by offering flexible visit scheduling to accommodate work and family commitments. This can be achieved through enabling evening, weekend, and virtual options for completing study visits.

Financial and Logistical Support

Reimbursing participants for travel, childcare support, and time from work missed can help remove logistical barriers to participation. Sponsors can also show appreciation for their time by providing additional compensation for completing study activities.

Incorporating Patient Feedback for Continuous Improvement

Embedding feedback mechanisms throughout the trial process enables real-time adjustments based on participant experiences. Tools like surveys and focus groups can provide valuable insights on aspects such as the clarity of informed consent documents and the overall trial environment. This iterative approach not only enhances patient satisfaction but also reinforces a commitment to making research more inclusive and responsive to women’s needs.

Leveraging Digital Health Technologies

Wearable Devices

Wearable technology is revolutionizing women’s health research by delivering continuous, real-time data that enhances the understanding of individual health patterns and conditions. Smartwatches, fitness trackers, and specialized biosensors can track menstrual cycles, pregnancy health, hormone fluctuations, and activity levels, providing valuable insights without invasive procedures. By enabling data collection in real-world settings, these devices improve the accuracy and relevance of research findings.

ePRO Applications

Electronic patient-reported outcome (ePRO) applications empower participants by enabling them to track symptoms, monitor medication adherence, and provide real-time feedback. These tools enhance patient engagement, fostering a greater sense of ownership over their health journey. For researchers, ePRO data supports more adaptive and responsive trial designs, allowing for real-time adjustments that improve study outcomes and better address participants' needs.

Improving Retention Through Patient-Centric Support

Retention is one of the biggest challenges in clinical trials, and dropout rates can be particularly high in women’s health studies. Strategies to improve retention include:

  • Clear Communication: Providing educational materials that explain study expectations, procedures, and potential benefits in patient-friendly language.
  • Continuous Engagement: Regular check-ins via digital health platforms, text reminders, or dedicated patient coordinators help participants stay involved.
  • Addressing Side Effects and Concerns: Offering accessible channels (i.e. 24-hour patient concierge contact) for participants to report and discuss side effects fosters trust and adherence while prioritizing safety.

Conclusion

By prioritizing women’s needs and patient centricity, clinical trials and RWE studies can be structured to optimize participation and sustain retention. As the industry shifts towards more inclusive and responsive research practices, these strategies will be essential for driving innovation and improving health outcomes for women worldwide.

Ready to raise the bar for your women’s health research? Lindus Health’s dedicated women’s health team is adept at employing these tactics so that your clinical trials or RWE studies are set up for success. Book a meeting with our team to get started.

Subscribe for more content
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Download now

Speak with an expert about your study.

Get your study done faster. Try the CRO that everyone is talking about.